Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Diseases × trimebutine 3-thiocarbamoylbenzenesulfonate × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 1 Neoplasms 1 Colorectal Neoplasms 1 Colonic Diseases 1 Agnosia 1

Interventions

trimebutine 3-thiocarbamoylbenzenesulfonate 1 pembrolizumab 1 alectinib 1 Oxaliplatin 1 Ocoxin 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01926444 2019-05-08

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

gicare Pharma Inc.

Phase 2 Completed

308 enrolled 14 charts

Gastrointestinal

Agnosia, Colonic Diseases, Neoplasms, Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡